Nitric oxide mediated effects of nebivolol in cardiorenal syndrome
Open Access
- 1 November 2019
- journal article
- research article
- Vol. 22 (11) , 1314-1324
Abstract
Objective(s): Despite several proposed mechanisms for the pathophysiology of cardiorenal syndrome (CRS), the exact mechanism remains unclear. Nitrosative stress has been argued as a key mechanism recently. Nebivolol is a beta-blocker with nitric oxide (NO)-releasing effect. In the present study, NO-mediated effects of two different treatment regimes of nebivolol in CRS were studied. Materials and Methods: Rats were divided into: sham-operated (sham-control), myocardial infarction (MI)-induced, (MI-control) early nebivolol-treated (MI-neb1) and late nebivolol-treated (Mı-neb2) groups. The effects of nebivolol were assessed both in the early and late period of MI by histologic, hemodynamic and biologic studies.Results: Developed MI model was in line with the heart failure with preserved ejection fraction. Focal and total tubular damage findings were observed in MI-control group both in early and late period of MI. In parallel, subclinical functional damage was transformed into chronic renal dysfunction in this group. Increased inducible nitric oxide synthase (iNOS) and endothelial NOS (eNOS) together with decreased neuronal NOS (nNOS) levels were in parallel with the increased inflammation and nitrosative stress biomarkers. Nebivolol effectively prevented both subclinical and clinical nephropathy. There was no statistical difference between the nebivolol treatment regimes.Conclusion: The beneficial effects of nebivolol were closely related to the reduction of nitrosative damages as well as hemodynamic alterations. The NO-mediated effects were: prevention of nitrosative damage by decreasing iNOS, preservation of nNOS in order to maintain glomerular filtration rate (GFR), and restoration of eNOS in the late period of MI. On contrary to our previous work, early nebivolol administration had a similar effect with delayed administration of nebivolol on CRS.Keywords
This publication has 49 references indexed in Scilit:
- Heart–kidney crosstalk and role of humoral signaling in critical illnessCritical Care, 2014
- Clinical Features of Cardio-Renal Syndrome in a Cohort of Consecutive Patients Admitted to an Internal Medicine WardThe Open Cardiovascular Medicine Journal, 2011
- Targeting Mitochondrial Oxidative Stress in Heart FailureJACC, 2011
- Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney diseaseAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Flow-activated transport events along the nephronCurrent Opinion in Nephrology and Hypertension, 2006
- Axial flow modulates proximal tubule NHE3 and H-ATPase activities by changing microvillus bending momentsAmerican Journal of Physiology-Renal Physiology, 2006
- Understanding Nitric Oxide Physiology in the Heart: A Nanomedical ApproachThe American Journal of Cardiology, 2005
- Triggering Mitochondrial Radical ReleaseHypertension, 2005
- Expression of endothelial nitric oxide synthase in developing rat kidneyAmerican Journal of Physiology-Renal Physiology, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005